Are you struggling with itchy skin?
The Study
- A study to evaluate the safety of Tapinarof Cream in kids with Extensive Atopic Dermatitis
Study Benefits
- Tapinarof is a new topical cream for inflammatory skin diseases
- It works by reducing inflammation in the skin
- The study drug is an anti-inflammatory agent and works to down regulate the expression of inflammatory cytokines including IL-4, IL-5, IL-6, and IL-13
- Open Label Study
- Non-steroidal medication
Study Volunteers Must Meet the Following Criteria
- Male or females
- 2-17 years of age
- Moderate to severe atopic dermatitis
Study Participant Expectations
- 6 study visits
- 1 phone call during course of the study
- Apply study drug daily
Cost
- There is no cost to participate
- Patients who qualify may be compensated for time and travel